Top

Published in:

Open Access 01-12-2023 | Respiratory Syncytial Virus Infection | Editorial

An update on respiratory syncytial virus

Authors: Antonio Piralla, Zhengrong Chen, Hassan Zaraket

Published in: BMC Infectious Diseases | Issue 1/2023

Abstract

Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infections resulting in a significant burden worldwide, particularly in children and older adults. This collection calls for original research papers that advance our understanding of the epidemiology, evolution, diagnosis, clinical management, and prevention of RSV infections.

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 Diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019 [published correction appears in Lancet. 2020;396(10262):1562]. Lancet. 2020;396(10258):1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9.CrossRef

GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower Respiratory Infections in 195 countries, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191–210. https://doi.org/10.1016/S1473-3099(18)30310-4.CrossRef

Savic M, Penders Y, Shi T, Branche A, Pirçon JY. Respiratory syncytial virus Disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13031. https://doi.org/10.1111/irv.13031. Epub 2022 Nov 11. PMID: 36369772; PMCID: PMC9835463.CrossRefPubMed

Rios Guzman E, Hultquist JF. Clinical and biological consequences of respiratory syncytial virus genetic diversity. Ther Adv Infect Dis. 2022;9:20499361221128091. https://doi.org/10.1177/20499361221128091. PMID: 36225856; PMCID: PMC9549189.CrossRefPubMedPubMedCentral

Lin GL, Golubchik T, Drysdale S, O’Connor D, Jefferies K, Brown A, de Cesare M, Bonsall D, Ansari MA, Aerssens J, Bont L, Openshaw P, Martinón-Torres F, Bowden R, Pollard AJ, RESCEU Investigators. Simultaneous viral whole-genome sequencing and Differential expression profiling in respiratory syncytial virus Infection of infants. J Infect Dis. 2020;222(Suppl 7):S666–71. https://doi.org/10.1093/infdis/jiaa448. PMID: 32702120.CrossRefPubMed

Rodgers L, Sheppard M, Smith A, Dietz S, Jayanthi P, Yuan Y, Bull L, Wotiz S, Schwarze T, Azondekon R, Hartnett K, Adjemian J, Kirking HL, Kite-Powell A. Changes in Seasonal Respiratory illnesses in the United States during the Coronavirus Disease 2019 (COVID-19) pandemic. Clin Infect Dis. 2021;73(Suppl 1):110–S117. https://doi.org/10.1093/cid/ciab311. PMID: 33912902; PMCID: PMC8135472.CrossRef

Hamid S, Winn A, Parikh R, Jones JM, McMorrow M, Prill MM, Silk BJ, Scobie HM, Hall AJ. Seasonality of respiratory Syncytial Virus - United States, 2017–2023. MMWR Morb Mortal Wkly Rep. 2023;72(14):355–61. https://doi.org/10.15585/mmwr.mm7214a1. PMID: 37022977; PMCID: PMC10078848.CrossRefPubMedPubMedCentral

Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, Rybak A, Ouldali N, Guiso N, Grimprel E. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51(5):418–23. Epub 2021 May 12. PMID: 33991720; PMCID: PMC8114587.CrossRefPubMedPubMedCentral

Pizzorno A, Padey B, Dulière V, Mouton W, Oliva J, Laurent E, Milesi C, Lina B, Traversier A, Julien T, Trouillet-Assant S, Rosa-Calatrava M, Terrier O. Interactions between severe Acute Respiratory Syndrome Coronavirus 2 replication and major respiratory viruses in human nasal epithelium. J Infect Dis. 2022;226(12):2095–104. https://doi.org/10.1093/infdis/jiac357. PMID: 36031537; PMCID: PMC9452145.CrossRefPubMed

10.

Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, detection, and New options for Prevention and Treatment. Clin Microbiol Rev. 2016;30:277–319.CrossRefPubMedCentral

11.

Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, et al. Nirsevimab for Prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386:837–46.CrossRefPubMed

12.

Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, et al. Bivalent Prefusion F vaccine in pregnancy to prevent RSV Illness in infants. N Engl J Med. 2023;388:1451–64.CrossRefPubMed

13.

Walsh EE, Pérez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N Engl J Med. 2023;388:1465–77.CrossRefPubMed

14.

Falsey AR, Williams K, Gymnopoulou E, Bart S, Ervin J, Bastian AR, et al. Efficacy and safety of an Ad26.RSV.preF–RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609–20.CrossRefPubMed

15.

Papi A, Ison MG, Langley JM, Lee D-G, Leroux-Roels I, Martinon-Torres F, et al. Respiratory Syncytial Virus Prefusion F protein vaccine in older adults. N Engl J Med. 2023;388:595–608.CrossRefPubMed

16.

Venkatesan P. First RSV vaccine approvals. The Lancet Microbe. 2023;4:e577.CrossRefPubMed

Title: An update on respiratory syncytial virus
Authors: Antonio Piralla
Zhengrong Chen
Hassan Zaraket
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Respiratory Syncytial Virus Infection
Influenza Virus
Published in: BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-023-08730-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Online commercial sex-seeking among female sex workers in south China: a cross-sectional study

Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study

Factors associated with the choice of having multiple sexual partners among male college students with casual heterosexual sex in Zhejiang Province, Eastern China

Analysis on epidemiological characters and HIV care continuum of HIV-infected students: a retrospective cohort study in Shandong province, China

Hyperinflammatory syndrome in a paediatric patient with a recent diagnosis of HIV/AIDS infection: hemophagocytic lymphohistiocytosis or immune reconstitution syndrome?

Temporal discrepancies in “rapid” HIV testing: explaining misdiagnoses at the point-of-care in Zimbabwe

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials